Using nationwide Danish registries we examined the long-term risk of cervical cancer in women diagnosed with cervical intraepithelial neoplasia grade 3 (CIN3) (including adenocarcinoma in situ (AIS)) on the cone compared to women with a normal cytology test. Initially, we identified women born , who were recorded as living in Denmark between January 1, 1978 and December 31, 2012. From the Pathology Data Bank information on CIN3 on the cone, margins status, histological type of CIN3 and cervical cytology results was extracted. Cox proportional hazard model was used to estimate the relative risk of subsequent cervical cancer. We included 59,464 women with CIN3 on the cone and 1,918,508 women with a normal cytology test. Overall, women diagnosed with CIN3 had a higher risk of subsequent cervical cancer compared to women with normal cytology (HR 5 2.06; 95%CI: 1.81-2.35). Analyses according to time since conization showed elevated risks in all time periods, and 25 years or more after conization the relative risk was significantly increased (HR 5 2.56; 95%CI: 1.37-4.77). Twenty years or more after conization, also women with negative margins had an increased relative risk (HR 5 2.49; 95%CI: 1.12-5.57). In addition, the long-term relative risk of cervical cancer varied with the different histological types of CIN3 and was highest for AIS (HR 5 7.50; 95%CI: 1.87-30.01, 10-14 years after conization). In conclusion, women diagnosed with CIN3 on the cone have a long-lasting increased risk of cervical cancer even when the margins on the cone are negative.
Introduction
Cervical cancer is the fourth most common cancer among women worldwide. 1 Accumulating evidence have established that persistent infection with high-risk human papillomavirus (HPV) is a necessary factor for the development of cervical intraepithelial neoplasia grade 3 (CIN3) and cervical cancer.
2
CIN3 is an intermediate stage in cancer progression, but the exact magnitude of progression rate is unknown. However, it has been estimated that if a CIN3 lesion is only treated with punch or wedge biopsy and there is cytological evidence of persistent disease, approximately 50% will progress to cervical cancer within 30 years. 3 The recommended treatment of CIN3 is excision of the lesion by conization, which reduces the risk of developing cervical cancer. 4 Although conization is an effective treatment, the longterm risk of cervical cancer is higher among women treated with conization than women with normal cytology test at screening 5, 6 and the general female population. [7] [8] [9] [10] Two studies from Sweden have shown that the risk of cervical cancer remains elevated for at least 20 years after diagnosis of CIN3. 7, 9 However, several of the existing studies are limited by small study populations or lack information on CIN grade or treatment type in the longterm risk analysis. Additional knowledge on the long-term risk of cervical cancer after conization is important to advance the knowledge on the natural history of cervical neoplasia after treatment. Furthermore, the current guidelines for the follow-up strategy after conization are varying between countries and further knowledge is important as a basis for planning the most optimal post-conization follow-up program. The aim of this nationwide cohort study was to examine the long-term risk of cervical cancer in women with a histologically confirmed CIN3 on a cone compared to women with a normal cytology test, and compared to the general female population. In addition, we examined the long-term risk of cervical cancer according to margin status and the histological type of CIN3.
Material and Methods

Study population
All Danish citizens are assigned a unique personal identification number, which is used as a personal identifier in national population and health databases and allows accurate linkage of data between registers. The Danish Civil Registration System contains information on personal identification number and other variables including date of birth, death, immigration and emigration. 11 Initially, we identified all women born between 1918 and 1990, who were alive and recorded as living in Denmark between January 1, 1978 and December 31, 2012. We excluded women from the study population if they had a cancer diagnosis (except nonmelanoma skin cancer) or total hysterectomy before start of follow-up. By linking the personal identification number of the women with the Pathology Data Bank, we retrieved information on all cases of CIN3 histologically diagnosed on a cone specimen. The nomenclature of cervical histology has changed over time in the Pathology Data Bank from mostly the WHO Dysplasia nomenclature with country-specific modifications until now almost exclusively the CIN classification. To accommodate this we defined "CIN3" in our study as including severe dysplasia, squamous cell carcinoma in situ, adenocarcinoma in situ (AIS) and CIN3. The Pathology Data Bank contains information on all cytological and histological examinations, including data on topography and morphology as well as dates for all examinations. 12 The registration is complete from all Danish pathology departments since the mid-1990s and most pathology departments have transferred information to the Pathology Data Bank from the mid-1990s back to 1978, however, data from this period is not entirely complete. A total of 59,464 women were diagnosed with CIN3 on the histological sample of the cone. In addition, we identified women who had at least one cervical cytology to establish a comparison group. The women contributed with follow-up time from the time of their first normal cytology test. Women with cytological or histological abnormalities before the normal cytology test were not included. A total of 1,918,508 women had a first normal cytology test and contributed with follow-up time.
Ascertainment of outcome
The Danish Cancer Registry is a nationwide registry that contains information about all types of cancer (topography and morphology). The registration was based on notification forms from hospitals, specialists and general practitioners until 2003. Subsequently, the Registry has been based on registrations mainly from the National Patient Registry.
Computerized checks are performed to identify logical errors and rare combinations, which are reviewed manually. The Cancer Registry is also supplemented by linkages to the Causes of Death Registry. 13 The personal identification numbers of the women were linked to the Danish Cancer Registry for information on cervical cancer by using the ICD-10 code C53. The cervical carcinomas were defined by the morphological subtypes 8010-8671 and 8940-8941. 
Ascertainment of educational level and margin status
Statistical analysis
Cox proportional hazard model with age as the underlying time scale was used to estimate hazard ratios (HRs) and corresponding 95% confidence interval (95%CI) for the association between CIN3 on cone and cervical cancer when compared to women with normal cytology. Women were followed from the age of 18 years, the age at January 1, 1978 or the age at immigration, whichever occurred latest, until their age at exit, defined as the age of emigration, death, end of follow-up (December 31, 2012), total hysterectomy, diagnosis of an anogenital cancer (including cervical, anal, vulvar and vaginal cancer) or rectal cancer, whichever came first. Only first diagnosis of an anogenital cancer was used because treatment might change the subsequent risk of another anogenital cancer. CIN3 on cone was treated as a time-dependent covariate. Women (including women with a previous normal cytology test) contributed with person-years as exposed from their first registered CIN3 on cone. Furthermore, the underlying hazard was stratified according to birth year in 1-year intervals to control for changes in exposure assessment and cancer incidence. To account for cases of underlying cervical cancers, events and person time experienced within the first year after conization were excluded. The proportional hazards assumption was tested using scaled Schoenfeld's residuals.
To assess the relative risk of cervical cancer in relation to time since conization, period of conization, histological types of CIN3 and margin status, we estimated HRs according to these variables. Time since conization was categorized as 1-4 years, 5-9 years, 10-14 years, 15-19 years, 20-24 years and 25 years and was treated as a time-dependent variable. Wider time intervals were used in the analysis of the margin status because of fewer events (negative margins: 1-4 years, 5-9 years, 10-14 years, 15-19 years and 20 years; positive and uncertain margins: 1-4 years, 5-9 years and 10 years). Calendar period of conization was grouped into <1990 and 1990-2012, and histological types of CIN3 included severe dysplasia, squamous cell carcinoma in situ and AIS. Furthermore, among women with CIN3 on a cone, the absolute risk of cervical cancer for negative and positive margins, respectively, as a function of years since conization was estimated by Aalen-Johansen estimator, taking into account competing risks from total hysterectomy, death, non-cervical anogenital cancers and rectal cancer. The women were censored at emigration and end of follow-up. Equivalent results for uncertain margins were excluded because of too few events.
We also calculated standardized incidence ratios (SIRs) comparing all women with CIN3 on the cone with the general female population. In addition, we compared women with negative margins on the cone with the general female population, and SIRs were also calculated by time since conization (1-4, 5-9, 10-14, 15-19 and 20 years). The expected numbers of cases were calculated by multiplying the accumulated person-years of the general female population of Denmark in 5-year age groups and calendar periods by cancer incidence rates. Analyses were adjusted for educational level, which was used as a time-dependent covariate that changed between three age intervals. In the age span 18-24 years the education level at age 18 was used, from 25 to 29 years the education level at age 25 was used and from 30 years and after the education level at age 30 was used. If information about education level was missing for one year, the next year within the age interval was searched.
All analyses were performed in R version 3.0.1. 15 The study was approved by the Danish Data Protection Agency.
Results
We identified 59,464 women with a CIN3 diagnosis on the histological sample of the cone contributing with a follow-up time of 663,925 person-years. The median age at conization was 32 years (range: 18-90 years). During the study period, 237 women were diagnosed with cervical cancer 1 year or more after CIN3 on cone. The overall SIR for women treated for CIN3 by conization to develop cervical cancer was 1.68 (95%CI: 1.47-1.90) compared to the general female population.
A total of 1,918,508 women had a normal cytology test and were followed for 34,493,494 person-years. Among women with a normal cytology 5,529 cases of cervical cancer were observed. The follow-up times for women with CIN3 on the cone and a normal cytology test according to level of education, calendar time and attained age are presented in Table 1 . Table 2 presents the risk of developing cervical cancer among women with CIN3 on the cone (n 5 59,464) compared to women with a normal cytology test (n 5 1,918,508) estimated by time since conization. Overall, the relative risk of developing cervical cancer was higher for women with CIN3 on the cone compared to women with a normal cytology test. The age-adjusted HR was 2.06 (95%CI: 1.81-2.35) and was virtually unchanged when additionally adjusting for education level (HR 5 2.03; 95%CI: 1.78-2.31). The relative risks were significantly higher in all time periods among women previously treated for CIN3 with conization compared to women with a normal cytology test. Specifically, the HR adjusted for age and education level was 2.10 (95%CI: 1.68-2.63) and 2.36 (95%CI: 1.37-4.07) after 1-4 years and 20-24 years following conization, respectively. Twenty-five years or more after conization the HR was 2.53 (95%CI: 1.36-4.72).
We examined the risk of cervical cancer according to the specific histological type of CIN3 on the cone by time since conization (Table 3) . Among women with CIN3 on cone, 37,124, 21,256 and 1,084 women had severe dysplasia, squamous cell carcinoma in situ and AIS, respectively. During the follow-up period, 95 women with severe dysplasia, 129 women with squamous cell carcinoma in situ and 13 women with AIS were diagnosed with cervical cancer. Overall, women with AIS had the highest relative risk of cervical cancer (HR 5 8.20; 95%CI: 4.76-14.15) followed by squamous cell carcinoma in situ (HR 5 2.64; 95%CI: 2.22-3.14) and severe dysplasia (HR 5 1.43; 95%CI: 1.17-1.75). Twenty-five years or more after conization the relative risk of cervical cancer was 2.68 (95%CI: 1.11-6.47) and 2.42 (95%CI: 1.00-5.82) for women with respectively severe dysplasia and squamous cell carcinoma in situ on the cone. For women diagnosed with AIS on the cone the HR was 7.50 (95%CI: 1.87-30.01) 10-14 years after conization.
We analyzed the risk of cervical cancer according to calendar period of conization. There was no significant difference in the relative risk of cervical cancer for women treated before 1990 (HR 5 1.94; 95%CI: 1.55-2.44) compared to women treated after 1990 (HR 5 2.07; 95%CI: 1.77-2.42) (p > 0.6). In addition, no difference in the relative risk between calendar periods was seen when analyzed by time since conization (data not shown).
The risk of cervical cancer was also examined according to margin status on the cone. Information on the margins was available for 36,144 women of which 27,192 (75%) were negative, 7,679 (21%) were positive and for 1,273 (4%) women the margin status was uncertain. A total of 46 and 35 women were diagnosed with cervical cancer in the follow-up period for women with negative and positive margins, respectively. Less than 5 women with uncertain margins were diagnosed with cervical cancer. We examined the absolute risk of incident cervical cancer for all women with CIN3 on cone (n 5 59,464) and for women with negative and positive margins in relation to follow-up time since conization (Fig. 1) . Generally, women with positive margins had a higher absolute risk of cervical cancer compared to women with negative margins. Both women with negative and positive margins had a continuous increase in absolute risk of cervical cancer with time since conization, however, the increase in risk with time was more substantial for women with positive margins than women with negative margins. Table 4 presents the HR of subsequent cervical cancer for women with respectively negative, positive or uncertain margins compared to women with a normal cytology test by time since conization. Overall, there was no increased relative risk of cervical cancer for women with negative margins (HR5 0.94; 95%CI: 0.70-1.25), however, 20 years or more after conization the HR was 2.49 (95%CI: 1.12-5.57). The relative risk was higher for women with positive margins (HR5 4.63; 95%CI: 3.31-6.48) and remained increased for more than 10 years after conization, although not statistically significant for the last period (HR5 2.88; 95%CI; 0.72-11.56). Women with uncertain margins had an insignificantly increased relative risk of cervical cancer in all time periods since conization, however, the analysis was limited by a limited number of cervical cancer cases.
Finally, we calculated standardized incidence rates (SIRs) of cervical cancer comparing women with negative margins on the cone with the general female population by time since conization. No significantly increased risk was seen within the first 15 years following conization for women with negative margins on the cone (data not shown). However, 20 years or more after conization women with negative margins had a significant and almost twice as high risk of cervical cancer compared to the general female population (SIR 5 1.90; 95%CI: 1.19-2.84).
Discussion
In this nationwide cohort study, we found that women previously treated for CIN3 by conization have an increased risk of developing cervical cancer compared to both the general female population and women with a normal cytology test. Importantly, this increased risk appears to be long lasting, as it persisted for 25 years or more after conization. The risk was largely determined by the margins status on the cone, however, 20 years or more after conization even women with negative margins had a significantly increased relative risk of cervical cancer.
Various mechanisms could explain the long-term increased risk of developing cervical cancer after conization. The increased risk might be a consequence of missed residual neoplasia after conization where cervical cancer develops from the precursor lesion that was initially treated. This could explain the very high risk found when the margins on the cone are positive i.e. with the presence of neoplasia. Cervical cancer diagnosed after complete excision of the lesion might develop from a de novo lesion, which could be a consequence of different factors. Lifestyle risk factors for acquiring new high-risk HPV infection such as number of partners, and number of partners' partners could remain throughout the life of the women and therefore constitute an increased risk despite successful treatment. Furthermore, the development of CIN3 indicates the presence of a persistent HPV infection indicating that women with CIN3 could have an immune dysregulation or genetic predisposition causing an inability to clear HPV infections leading to new progressive cervical neoplasia. Previous studies have reported a long-term increased risk of cervical cancer for 8 years or more after conization or CIN diagnosis. [5] [6] [7] [8] [9] [10] [16] [17] [18] In a register-based Swedish study following approximately 130,000 women diagnosed with CIN3 for subsequent cervical cancer, they found a significantly increased risk more than 25 years after CIN3 diagnosis compared to the general female population (SIR 5 1.77; 95%CI: 1.32-2.20). 7 Several of the studies only calculate SIR to compare the risk of cervical cancer in cohorts of women treated for or diagnosed with CIN with that of the general female population 7-10 but using this method, it is not possible to adjust for potentially confounding factors except for age and calendar period. In addition, none of the previous studies assessed the role of margin status on the cone or the histological subtypes included in CIN3 in the long-term risk analysis. Finally, most studies were limited by small study populations, had limited follow-up time, or had no information on CIN grade or treatment type.
All CIN3 lesions included in our study were treated with an excisional technique, including cold knife conization, carbon dioxide laser conization or loop electrosurgical excision procedure (LEEP) where cervical tissue, is preserved for histopathological evaluation. Since the introduction of LEEP in 1989, the use of laser conization and cold knife conization has become very rare in Denmark. Furthermore, there has been an increased awareness of possible side effects of conization such as increased risk of future preterm delivery especially if the excised cone is large. 19, 20 A more conservative treatment of CIN3 could potentially leave residual neoplasia at risk of progressing to cervical cancer and it has previously been found that the risk of cervical cancer following CIN3 has increased from the 1960s to 2000. 7 We did not find a difference in the risk of cervical cancer for women treated before and after 1990.
In the Danish Pathology Data Bank, the nomenclature of cervical histology has evolved from mostly the WHO Dysplasia nomenclature to now almost exclusively use of the CIN nomenclature with CIN3 corresponding to severe dysplasia and carcinoma in situ. 21 We found that women with squamous cell carcinoma in situ might have a slightly higher risk of cervical cancer after conization compared to women with severe dysplasia, however, 25 years or more after conization the risk was very similar for the two groups. Women with AIS in the cone had a significantly higher long-term risk of cervical cancer compared to squamous cell lesions, which could be explained by the fact that AIS is often located higher in the cervical canal and therefore harder to treat with conization. 22 Women treated with conization constitute a high-risk population and safe return to routine cervical screening is complex. Previously, European and North American guidelines for follow-up programs after conization have recommended repeated annual cytology for 5-10 years before returning to routine screening. Today, the guidelines are more heterogeneous between different areas of the world. [23] [24] [25] The 2012 ASCCP Consensus Guidelines recommended follow-up for at least 20 years after diagnosis regardless of age at diagnosis. 23 The Danish guidelines from 2012 recommend co-testing with cytology and HPV test 6 months after treatment. 21 If the woman has negative margins, normal cytology and negative HPV test she can return to the primary screening program. Women included in our study were followed until 2012 and therefore only followed with cytology tests. The implementation of HPV testing will improve the sensitivity of testing for cervical neoplasia and potentially influence the long-term risk of developing cervical cancer. In addition, p16 and other immunostains, cytogenetics and other markers could in the future be important in the 
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management and follow-up strategy of women diagnosed with CIN3. Finally, it could be relevant to consider offering the women post-conization prophylactic HPV vaccination, which potentially could protect them from future acquisition of the most carcinogenic HPV types and new progressive cervical neoplasia. 26 The strengths of our nationwide cohort study are the large study population, the prospective design and long follow-up time. As all Danish citizens have a unique personal identification number that is used in all nationwide registers, we had virtually complete follow-up. In addition, we consider that the validity of our outcome is high because the Danish Cancer Registry is accurate and virtually complete. 27, 28 Finally, we were able to adjust for educational level. The limitations include the fact that registration of exposure in the Pathology Data Bank is not entirely complete until the mid-1990s. This implies that we might have underestimated the relative risk as older women in the study population could have been treated with conization for a CIN3 lesion before this time without being registered with this diagnosis. In our study, diagnosis of a non-cervical anogenital cancer was treated as a competing event, which could slightly underestimate the risk of cervical cancer after conization, as some of the noncervical anogenital cancers might have originated in the cervix. In addition, we did not have information on HPV status following conization or margin status for all of the women treated for CIN3 by conization.
In conclusion, our study provides further evidence that women diagnosed with CIN3 on the cone have a long-lasting increased risk of cervical cancer, which, in our study, persisted for 25 years or more after conization. The risk was largely influenced by the margin status on the cone, but even women with negative margins had a significantly increased risk more than 20 years after conization compared to both the general female population and women with a normal cytology test. These findings points to the complexity and challenges of the post-conization follow-up program and adds important knowledge to the natural history of cervical neoplasia. 
